期刊文献+

肺癌证候研究现状 被引量:2

Research on the Present Condition of the Lung Cancer Syndrome
下载PDF
导出
摘要 原发性支气管肺癌是全球常见的恶性肿瘤之一,居我国恶性肿瘤死因之首,非小细胞肺癌占全部肺癌的75%~80%。通过对1998~2009年肺癌证候相关研究文献分析、总结可知,目前肺癌中医证候研究主要是中医证候与TNM分期相关性研究、预后相关性研究、病理分型相关性研究、病因病机研究及中医证候规范化研究等。并提出开展肺癌证候的动态变化与预后相关性研究,特别要重视舌象变化在肺癌辨证及预后中的重要性,进一步将现代医学诊疗手段整合到肺癌中医证候的客观化研究。 The lung cancer is a common malignant tumor all over the world,which is the leading cause of cancer death in China,and about 75%to 80%of lung cancers are non-small cell lung carcers.According to the lung cancer syndrome documents from 1998 to 2009,the lung cancer syndrome research on the present condition are as follows:the lung cancer syndrome is correlated with the stages of TNM,types of pathology,prognosis,etiology and?pathological mechanism,standards study,etc.It is?essential to study the correlation between the lung cancer syndrome changes with prognosis,particularly to observe tongue inspection change as prognostic factor,and further modern measures to integrate into the lung cancer syndrome objectification study.
出处 《医学综述》 2010年第23期3580-3582,共3页 Medical Recapitulate
基金 上海市重点优势学科建设项目(YO3O2) 青岛市开发区科委资助项目(2008-2-17)
关键词 肺癌 恶性肿瘤 中医证候 Lung cancer Malignant tumor Syndrome
  • 相关文献

参考文献26

  • 1第三次全国死因调查主要情况[J].中国肿瘤,2008,17(5):344-345. 被引量:255
  • 2William WN Jr,Kies MS,Fossella FV,et al.Phase 2 study of carboplatin,docetaxel,and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer[J].Cancer,2010,116(10):2401-2408.
  • 3Lee SM,Rudd R,Woll PJ,et al.Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and carboplatin in advanced non-small-cell lung cancer[J].J Clin Oncol,2009,27(31):5248-5254.
  • 4Tan EH,Rolski J,Grodzki T,et al.Global Lung Oncology Branch trial 3(GLOB3):final results of a randomised multinational phase III study alternating oral and i.v.vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer[J].Ann Oncol,2009,20(7):1249-1256.
  • 5Ramalingam S,Perry MC,La Rocca RV,et al.Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer[J].Cancer,2008,113(3):542-546.
  • 6Belani CP,Schreeder MT,Steis RG,et al.Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer:a multicenter phase 2 study[J].Cancer,2008,113(9):2512-2517.
  • 7徐振晔,金长娟,沈德义,李敏,周卫东,朱晏伟,张铭,邓海滨,王中奇,李蕾,寿伟臻,郑展.中医药分阶段结合化疗治疗晚期非小细胞肺癌的临床研究[J].中国中西医结合杂志,2007,27(10):874-878. 被引量:64
  • 8孙燕,林洪生,朱允中,冯继锋,陈正堂,李攻戍,张湘茹,张宗岐,唐俊舫,史美祺,郝学志,韩慧.长春瑞滨合并顺铂(NP)加参一胶囊或安慰剂治疗晚期非小细胞肺癌的多中心双盲随机临床研究报告[J].中国肺癌杂志,2006,9(3):254-258. 被引量:80
  • 9周岱翰,林丽珠,周宜强,罗荣城,刘魁凤,贾英杰,陈继跃,牛喜伟,苏碧茹,鲁江,王树堂.益气除痰法延长非小细胞肺癌中位生存期的作用[J].中医杂志,2005,46(8):600-602. 被引量:80
  • 10刘嘉湘,施志明,李和根,徐振晔,朱晏伟,赵丽红,高虹,刘苓霜,朱惠蓉,张晖.益肺抗瘤饮治疗271例非小细胞肺癌研究[J].医学研究通讯,2003,32(3):23-24. 被引量:29

二级参考文献111

共引文献785

同被引文献46

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部